TrialEndocrinology and metabolism (Seoul, Korea)2021

Romosozumab in Postmenopausal Korean Women with Osteoporosis: A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study.

Ki-Hyun Baek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.